Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.57-$16.93
Market Cap
$7.7M
Shares Short
2,823

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
-$7.8M
Diluted EPS
-$7.80

News

See more

Yahoo Finance • 5 months ago

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

Yahoo Finance • 5 months ago

CURX Investors Have Opportunity to Join Curanex Pharmaceuticals Inc Fraud Investigation with the Schall Law Firm

Yahoo Finance • 6 months ago

Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care

Yahoo Finance • 6 months ago

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

About

CEO
Mr. Jun Liu
Address
2 Jericho Plaza, Jericho, NY, United States, 11753
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
6